To summarize the nursing experience of a patient with pulmonary fibrosis after COVID-19 undergoing lung transplantation complicated with viral encephalopathy. In view of the complex condition,prominent encephalopathy symptoms,high bleeding risk and other problems,we adopted early warning of viral encephalopathy after lung transplantation,passive-active progressive pulmonary rehabilitation training,the platelet count orientated anti-coagulation management,dynamic immunosuppressive drugs management,and auditory verbal feedback cognitive training. After 58 days of treatment and nursing,the patient‘s condition was stable and discharged from hospital,and the patient was in good condition during 2 months of follow-up after discharge.
GUO Luyao
,
ZENG Fei
,
LIANG Jiangshuyuan
,
CAI Lingyun
,
GU Peipei
. Nursing care of a patient with pulmonary fibrosis after COVID-19 undergoing lung transplantation complicated with viral encephalopathy[J]. Chinese Journal of Emergency and Critical Care Nursing, 2024
, 5(7)
: 645
-648
.
DOI: 10.3761/j.issn.2096-7446.2024.07.013
[1] Michalski JE,Kurche JS,Schwartz DA.From ARDS to pulmonary fibrosis:the next phase of the COVID-19 pandemic?[J]. Transl Res,2022,241:13-24.
[2] 焦国慧,王梓涛,陈静瑜. 肺移植全球发展概况与展望[J]. 器官移植,2022,13(4):417-424.
Jiao GH,Wang ZT,Chen JY.Current status and prospect of global development of lung transplantation[J]. Organ Transplant,2022,13(4):417-424.
[3] Eid AJ,Ardura MI,AST Infectious Diseases Community of Practice. Human parvovirus B19 in solid organ transplantation:guidelines from the American society of transplantation infectious diseases community of practice[J]. Clin Transplant,2019,33(9):e13535.
[4] Feng SW,Zeng DX,Zheng JW,et al.New insights of human parvovirus B19 in modulating erythroid progenitor cell differentiation[J]. Viral Immunol,2020,33(8):539-549.
[5] Qiu JM,Söderlund-Venermo M,Young NS.Human parvoviruses[J]. Clin Microbiol Rev,2017,30(1):43-113.
[6] Siciliano V,Rosà T,del Vecchio P,et al. Viral encephalitis in adults:a narrative review[J]. Rev Recent Clin Trials,2022,17(4):259-267.
[7] Stollings JL,Balas MC,Chanques G.Evolution of sedation management in the intensive care unit(ICU)[J]. Intensive Care Med,2022,48(11):1625-1628.
[8] Abidi Y,Kovats Z,Bohacs A,et al.Lung transplant rehabilitation-a review[J]. Life (Basel),2023,13(2):506.
[9] 兰美娟,曾妃,梁江淑渊. 双肺移植患者肺康复方案的构建及应用[J]. 中华护理杂志,2022,57(6):659-665.
Lan MJ,Zeng F,Liang JSY.Construction and application of a pulmonary rehabilitation program in patients with double lung transplantation[J]. Chin J Nurs,2022,57(6):659-665.
[10] 范立,吴波,卫栋,等. 肺移植围术期静脉血栓栓塞症的防治与管理[J]. 实用器官移植电子杂志,2021,9(5):411-414.
Fan L,Wu B,Wei D,et al.Prevention and management of venous thromboembolism during perioperative period of lung transplantation[J]. Pract J Organ Transplant Electron Version,2021,9(5):411-414.
[11] Small B,Au J,Brink H,et al.Induction and maintenance immunosuppression in lung transplantation[J]. Indian J Thorac Cardiovasc Surg,2022,38(Suppl 2):300-317.
[12] Scheffert JL,Raza K.Immunosuppression in lung transplantation[J]. J Thorac Dis,2014,6(8):1039-1053.
[13] Bohmwald K,Andrade CA,Gálvez NMS,et al.The causes and long-term consequences of viral encephalitis[J]. Front Cell Neurosci,2021,15:755875.
